Holen Sie sich die Stockscreener-App
78.75
3.85%
2.92
Handel nachbörslich:
79.00
0.25
+0.32%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$75.83
Offen:
$76.49
24-Stunden-Volumen:
865.73K
Relative Volume:
1.00
Marktkapitalisierung:
$12.51B
Einnahmen:
$1.17B
Nettoeinkommen (Verlust:
$150.71M
KGV:
83.78
EPS:
0.94
Netto-Cashflow:
$245.03M
1W Leistung:
+5.38%
1M Leistung:
+7.63%
6M Leistung:
+4.36%
1J Leistung:
+11.99%
1-Tages-Spanne:
$76.41
$78.83
1-Wochen-Bereich:
$73.67
$78.83
52-Wochen-Spanne:
$61.16
$85.57
Bio Techne Corp Stock (TECH) Company Profile
Firmenname
Bio Techne Corp
Sektor
Branche
Telefon
(612) 379-8854
Adresse
614 MCKINLEY PL N E, MINNEAPOLIS, MN
Vergleichen Sie TECH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TECH
Bio Techne Corp
|
78.75 | 12.51B | 1.17B | 150.71M | 245.03M | 0.94 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Bio Techne Corp Stock (TECH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-05-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-02-08 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-02-02 | Herabstufung | Stifel | Buy → Hold |
| 2023-12-07 | Eingeleitet | UBS | Buy |
| 2023-08-28 | Eingeleitet | William Blair | Outperform |
| 2023-01-10 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-04-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2021-09-15 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-08 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2021-02-23 | Hochstufung | Stifel | Hold → Buy |
| 2021-01-25 | Bestätigt | The Benchmark Company | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-07-15 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-05-27 | Herabstufung | Stifel | Buy → Hold |
| 2020-05-14 | Eingeleitet | The Benchmark Company | Buy |
| 2020-01-08 | Fortgesetzt | Stephens | Overweight |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Neutral |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-07-02 | Hochstufung | Janney | Neutral → Buy |
| 2019-01-14 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2018-10-31 | Herabstufung | Craig Hallum | Buy → Hold |
| 2018-10-17 | Eingeleitet | Goldman | Neutral |
| 2018-06-15 | Eingeleitet | Argus | Buy |
| 2017-07-13 | Eingeleitet | Wells Fargo | Market Perform |
| 2017-02-09 | Eingeleitet | Citigroup | Buy |
| 2017-01-18 | Eingeleitet | Deutsche Bank | Buy |
| 2016-11-10 | Fortgesetzt | Leerink Partners | Outperform |
| 2015-01-21 | Bestätigt | Robert W. Baird | Outperform |
| 2013-09-20 | Hochstufung | Robert W. Baird | Neutral → Outperform |
Alle ansehen
Bio Techne Corp Aktie (TECH) Neueste Nachrichten
ScaleReady Announces a G-Rex® Grant has been awarded to BrainChild Bio - Yahoo Finance
Bio-Techne Earnings Preview: What To Expect - Barchart
Bio-Techne Co. (NASDAQ:TECH) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Bio-Techne Corp. stock outperforms competitors on strong trading day - MarketWatch
Is There Now An Opportunity In Bio-Techne Corporation (NASDAQ:TECH)? - Yahoo Finance
TECH Stock Might Rise From the Expansion of Designer Protein Portfolio - Yahoo Finance
Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine - WV News
Single-use Bioprocessing Probes and Sensors Market Forecast to Reach $10.95 Billion by 2034 - GlobeNewswire Inc.
ScaleReady Announces a G-Rex® Grant has been awarded to Seattle Children's Therapeutics - Yahoo Finance
GAMMA Investing LLC Buys 333 Shares of Bio-Techne Co. (NASDAQ:TECH) - Defense World
Bio-Techne Corp. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Bio-Techne wins patent case against Miltenyi Biotec - Investing.com
BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC - Yahoo Finance
3 Genomic Stocks Unlocking the Secrets of DNA - Inkl
BNTX: 3 Genomic Stocks Unlocking the Secrets of DNA - StockNews.com
JPMorgan Chase & Co. Sells 280,782 Shares of Bio-Techne Co. (NASDAQ:TECH) - Defense World
Bio-Techne Corp. stock outperforms competitors despite losses on the day - MarketWatch
Short Interest in Bio-Techne Co. (NASDAQ:TECH) Drops By 14.0% - MarketBeat
Bio-Techne Co. (NASDAQ:TECH) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Bio-Techne Corp. stock rises Tuesday, still underperforms market - MarketWatch
How Is Bio-Techne’s Stock Performance Compared to Other Biotechnology Stocks? - Nasdaq
How Is Bio-Techne’s Stock Performance Compared To Other Biotechnology Stocks? - Barchart
Bio-Techne Inks New Agreement With Waters Corporation: Stock to Gain? - Yahoo Finance
BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE - Financial Times
Bio-Techne Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Bio-Techne partners with Waters for biotherapeutic tech - Investing.com
BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT - Quantisnow
ScaleReady awards a G-Rex® Grant to Moonlight Bio - Quantisnow
Lord Abbett & CO. LLC Has $23.73 Million Stock Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Bio-Techne Co. (NASDAQ:TECH) Short Interest Up 15.6% in November - MarketBeat
Bio-Techne Co. (NASDAQ:TECH) Shares Sold by Toronto Dominion Bank - MarketBeat
Oddo BHF Asset Management Sas Invests $1.19 Million in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Barclays PLC Reduces Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Bio-Techne Launches ESR1 Mutation Monitoring Assay: Stock to Gain? - MSN
National Bank of Canada FI Purchases 37,181 Shares of Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY - Quantisnow
S&P 500 Futures Rise in Premarket Trading; Bausch + Lomb, Bio-Techne Lag - Barron's
West Sac-based GeminiBio acquires a large serum producer's brands, customers - The Business Journals
BIO-TECHNE LAUNCHES ESR1 MUTATION MONITORING ASSAY - Yahoo Finance
Wellington Management Group LLP Sells 147,797 Shares of Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
State Street Corp Grows Stock Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Tenere Capital LLC Grows Stock Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Worldquant Millennium Advisors LLC Buys 22,185 Shares of Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Polar Asset Management Partners Inc. Lowers Stock Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Janus Henderson Group PLC Lowers Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Can Mixed Financials Have A Negative Impact on Bio-Techne Corporation's 's (NASDAQ:TECH) Current Price Momentum? - Yahoo Finance
PEAK6 Investments LLC Invests $698,000 in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Exosome Research Products Industry Research Report 2023-2030, Featuring AMS, Bio-Techne, Lonza, Miltenyi Biotech, Nanosomix, Norgen Biotek, NX Pharmagen, Qiagen, SBI, Thermo Fisher Scientific - Yahoo Finance
Finanzdaten der Bio Techne Corp-Aktie (TECH)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.81%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):